Rubraca Evrópusambandið - íslenska - EMA (European Medicines Agency)

rubraca

pharmaand gmbh - rucaparib camsylate - Æxli í eggjastokkum - Æxlishemjandi lyf - rubraca is indicated as monotherapy for the maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. rubraca er ætlað eitt og sér til að viðhalda meðferð fullorðinn sjúklinga með platínu-viðkvæm fallið hágæða þekju blöðrur, eggjaleiðara, eða aðal kviðarholi krabbamein sem eru í svar (heill eða hluta) til að platínu-byggt lyfjameðferð.

Isturisa Evrópusambandið - íslenska - EMA (European Medicines Agency)

isturisa

recordati rare diseases - osilodrostat fosfórinn - cushing heilkenni - barksterar til almennrar notkunar - isturisa er ætlað fyrir meðferð innræn eg er heilkenni í fullorðnir.

Tabrecta Evrópusambandið - íslenska - EMA (European Medicines Agency)

tabrecta

novartis europharm limited  - capmatinib dihydrochloride monohydrate - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Zonnic Pepparmint Munnholsúði, lausn 1 mg/úða Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zonnic pepparmint munnholsúði, lausn 1 mg/úða

niconovum ab - nicotinum - munnholsúði, lausn - 1 mg/úða

Zonnic Mint Munnholspúði 4 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zonnic mint munnholspúði 4 mg

niconovum ab - nicotinum - munnholspúði - 4 mg

Diltiazem HCl Alvogen (Dilmin) Forðatafla 120 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

diltiazem hcl alvogen (dilmin) forðatafla 120 mg

alvogen ehf. - diltiazemum hýdróklóríð - forðatafla - 120 mg

Phenoleptil Tafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

phenoleptil tafla 100 mg

dechra regulatory b.v. - phenobarbitalum inn - tafla - 100 mg

Phenoleptil Tafla 25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

phenoleptil tafla 25 mg

dechra regulatory b.v. - phenobarbitalum inn - tafla - 25 mg

Hydrokortison Orion (Hydrocortisone Orion) Tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

hydrokortison orion (hydrocortisone orion) tafla 10 mg

orion corporation - hydrocortisonum inn - tafla - 10 mg

Lytgobi Evrópusambandið - íslenska - EMA (European Medicines Agency)

lytgobi

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastic lyfjum - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.